Shonna Wagaman
Family · Leonardtown, MDNPI 1760091581
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,956 of the $12,890 with a category attached, or 85.0%. It is spread thinly across 28 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $4,898, 2.5 times the $1,927 reported in 2021. Among family clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 487 payments — averaging $26.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Medtronic$2K
- AbbVie$2K
- Scilex Pharmaceuticals Inc.$2K
- Abbott$1K
- Biohaven Pharmaceuticals, Inc.$1K
- plus $3K from 22 others
What the payments were for
- Consulting fees$8006%
- Travel & lodging$9407%
- Food & beverage$10,95685%
- Education$1952%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 106 | $2,327 |
| Medtronic | 40 | $2,163 |
| AbbVie(2 entities) | 92 | $1,842 |
| Scilex Pharmaceuticals Inc. | 79 | $1,574 |
| Abbott | 19 | $1,047 |
| Biohaven Pharmaceuticals, Inc. | 15 | $1,039 |
| Pfizer | 41 | $808 |
| Biohaven Pharmaceutical Holding Company Ltd. | 23 | $522 |
| Nevro Corp. | 15 | $424 |
| Collegium Pharmaceutical, Inc. | 11 | $228 |
| Amgen | 10 | $168 |
| Redhill Biopharma Inc. | 7 | $156 |
| Biodelivery Sciences International, Inc. | 9 | $116 |
| Neurocrine Biosciences, Inc. | 1 | $81 |
| Electronic Waveform Lab, Inc. | 2 | $70 |
| Azurity Pharmaceuticals, Inc. | 1 | $60 |
| Hikma Pharmaceuticals USA | 2 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $35 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| GRT US Holding, Inc. | 1 | $23 |
| Globus Medical | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Vertex | 1 | $19 |
| Averitas Pharma Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| International Rehabilitative Sciences, Inc | 1 | $15 |
| Curonix LLC | 1 | $14 |
| Impel Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,890 in reported general payments places this provider in the 95th percentile of 2,843 family providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 460 | $80,928 |
| Nurtec OdtRimegepant Sulfate | 23 | $24,006 |
| MovantikNaloxegol Oxalate | 49 | $19,599 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 592 | $15,802 |
| Diclofenac Sodium | 510 | $15,708 |
| BelbucaBuprenorphine Hcl | 21 | $15,658 |
| Oxycodone Hcl | 845 | $14,778 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 437 | $14,181 |
| Naloxone Hcl | 185 | $12,612 |
| Oxymorphone Hcl ErOxymorphone Hcl | 23 | $11,377 |
| Gabapentin | 735 | $10,629 |
| ZtlidoLidocaine | 16 | $10,571 |
| SymproicNaldemedine Tosylate | 21 | $9,614 |
| Pregabalin | 314 | $6,245 |
| Cyclobenzaprine Hcl | 373 | $5,277 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $808 | $24,00623 claims |
| Redhill Biopharma Inc.Movantik | $156 | $19,59949 claims |
| Collegium Pharmaceutical, Inc.Belbuca | $228 | $15,65821 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $1,574 | $10,57116 claims |
| Hikma Pharmaceuticals USAMorphine Sulfate | $42 | $1,32638 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,843 family providers in Maryland.
Other family in Leonardtown
- Erika HoffmanPotomac$226K
- Caroline MansySalisbury$106K
- Hazel Jones-ParkerBaltimore$96K
- Brittany WilsonBaltimore$88K
- Ariana ChaoLutherville$85K
- Meredith SagalHunt Valley$82K
- Sharon Dudley-BrownBel Air$67K
- Joy MaulikSalisbury$47K
- Kristin AttiogbeChevy Chase$42K
- Sametta SanyaoluFulton$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.